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Abstract	  	  The	   radiohalogens	   123I,	   124I,	   125I,	   131I,	   and	   211At	   are	   routinely	   used	   or	   proposed	   for	  diagnostic	  and	  therapeutic	  purposes.	  The	  different	  characteristics	  and	  application	  areas	  of	   these	   radioiodine	   isotopes,	   together	  with	   the	   possibility	   to	   bind	   them	   to	   the	   same	  carrier	   molecule,	   give	   many	   advantages,	   for	   example,	   by	   enabling	   relevant	  biodistribution	  and	  dosimetric	  studies	  important	  for	  dose-­‐planning	  before	  radionuclide	  therapy.	  211At,	  with	  its	  relatively	   long	  half-­‐life,	  stable	  daughter	  nuclide,	  and	  production	  and	   labelling	   possibilities	   is	   considered	   as	   one	   of	   the	   most	   attractive	   alpha	   particle	  emitters	  in	  radionuclide	  therapy.	  With	  growing	  use	  of	  radiohalogens	  in	  both	  preclinical	  and	  clinical	  studies	  there	  is	  a	  need	  for	  accurate	  species-­‐specific	  dosimetric	  models	  both	  for	   tumours	   and	   normal	   tissues.	   The	   thyroid	   gland	   has	   shown	   a	   high	   uptake	   of	  radioiodide	   and	   free	   211At	   and	   is,	   therefore,	   considered	   as	   an	   organ	   at	   risk.	   It	   is	   thus	  critical	   to	   be	   able	   to	   accurately	   calculate	   the	   absorbed	   dose	   in	   the	   thyroid.	   Accurate	  dosimetry	   is	   also	   important	   for	   radiation	   protection	   purposes	   for	   personnel	   handling	  radiohalogens	  and	  for	  populations	  exposed	  to	  radioiodine,	  e.g.,	  at	  a	  nuclear	  accident.	  	  The	   MIRD	   formalism	   is	   commonly	   used	   for	   calculating	   the	   mean	   absorbed	   dose,	  assuming	   a	   homogeneous	   distribution	   of	   the	   radionuclide	   within	   the	   thyroid	   gland.	  Several	  studies	  have	  shown	  heterogeneous	  distribution	  of	  radioiodine	  and	  211At	  within	  the	  thyroid	  gland.	  	  In	   this	   work,	   geometrical	   models	   were	   developed	   for	   different	   species:	   man,	   rat	   and	  mouse.	   Microdosimetric	   calculations	   for	   heterogeneous	   distributions	   of	   the	   different	  radiohalogens	  in	  these	  thyroid	  models	  were	  performed	  using	  MCNPX	  Monte	  Carlo	  code	  and	  recent	  nuclear	  decay	  data.	  The	  results	  showed	  large	  differences	  in	  mean	  absorbed	  dose	  compared	  with	  MIRD	  formalism.	  	  The	  heterogeneity	  in	  absorbed	  dose	  within	  the	  thyroid	  depends	  on	  the	  type	  and	  energy	  of	  the	  emitted	  particles.	  For	  example,	  131I	  emits	  high-­‐energy	  beta	  particles	  with	  range	  up	  to	   2	   mm	   in	   tissue,	   where	   the	   absorbed	   dose	   distribution	   within	   the	   thyroid	   is	   less	  dependent	  on	  the	  radionuclide	  distribution.	  On	  the	  other	  hand,	  for	  211At	  emitting	  alpha	  particles	  with	   short	   range	   in	   tissue	   (48-­‐70	   μm),	   and	   for	   125I	   emitting	   Auger	   electrons	  with	  very	  short	  range	  in	  tissue	  (from	  a	  fraction	  of	  a	  nm	  up	  to	  20	  μm),	  the	  absorbed	  dose	  distribution	  will	  be	  more	  dependent	  on	  the	  radiohalogen	  distribution.	  	  The	   results	   also	   demonstrate	   the	   importance	   of	   using	   species-­‐specific	   models	   for	  dosimetric	  calculations	  for	  thyroid	  and	  other	  heterogeneous	  tissues,	  enabling	  dosimetric	  translations	  between	  different	  species.	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